Structure

Physi-Chem Properties

Molecular Weight:  424.19
Volume:  438.38
LogP:  5.48
LogD:  3.742
LogS:  -2.993
# Rotatable Bonds:  3
TPSA:  96.22
# H-Bond Aceptor:  6
# H-Bond Donor:  3
# Rings:  4
# Heavy Atoms:  6

MedChem Properties

QED Drug-Likeness Score:  0.633
Synthetic Accessibility Score:  3.961
Fsp3:  0.4
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  1
Golden Triangle Rule:  Accepted
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -4.797
MDCK Permeability:  1.4016384739079513e-05
Pgp-inhibitor:  0.171
Pgp-substrate:  0.954
Human Intestinal Absorption (HIA):  0.01
20% Bioavailability (F20%):  0.827
30% Bioavailability (F30%):  0.094

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.051
Plasma Protein Binding (PPB):  97.22342681884766%
Volume Distribution (VD):  1.082
Pgp-substrate:  3.7988576889038086%

ADMET: Metabolism

CYP1A2-inhibitor:  0.328
CYP1A2-substrate:  0.2
CYP2C19-inhibitor:  0.87
CYP2C19-substrate:  0.099
CYP2C9-inhibitor:  0.872
CYP2C9-substrate:  0.917
CYP2D6-inhibitor:  0.91
CYP2D6-substrate:  0.251
CYP3A4-inhibitor:  0.616
CYP3A4-substrate:  0.219

ADMET: Excretion

Clearance (CL):  13.913
Half-life (T1/2):  0.18

ADMET: Toxicity

hERG Blockers:  0.038
Human Hepatotoxicity (H-HT):  0.857
Drug-inuced Liver Injury (DILI):  0.681
AMES Toxicity:  0.017
Rat Oral Acute Toxicity:  0.755
Maximum Recommended Daily Dose:  0.94
Skin Sensitization:  0.782
Carcinogencity:  0.441
Eye Corrosion:  0.003
Eye Irritation:  0.104
Respiratory Toxicity:  0.944

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC474021

Natural Product ID:  NPC474021
Common Name*:   (2S)-3',5,7-Trihydroxy-2',2'-Dimethyl-8'-(3-Methylbut-2-Enyl)-2,6'-Bichroman-4-One
IUPAC Name:   (2S)-5,7-dihydroxy-2-[3-hydroxy-2,2-dimethyl-8-(3-methylbut-2-enyl)-3,4-dihydrochromen-6-yl]-2,3-dihydrochromen-4-one
Synonyms:  
Standard InCHIKey:  WJBWITXUNBMVLF-AIBWNMTMSA-N
Standard InCHI:  InChI=1S/C25H28O6/c1-13(2)5-6-14-7-15(8-16-9-22(29)25(3,4)31-24(14)16)20-12-19(28)23-18(27)10-17(26)11-21(23)30-20/h5,7-8,10-11,20,22,26-27,29H,6,9,12H2,1-4H3/t20-,22?/m0/s1
SMILES:  CC(=CCC1=CC(=CC2=C1OC(C(C2)O)(C)C)C3CC(=O)C4=C(C=C(C=C4O3)O)O)C
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL458555
PubChem CID:   44589132
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000261] Phenylpropanoids and polyketides
      • [CHEMONTID:0000334] Flavonoids
        • [CHEMONTID:0000337] Flavans
          • [CHEMONTID:0003643] 3'-prenylated flavans
            • [CHEMONTID:0003506] 3'-prenylated flavanones

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO8526 Erythrina abyssinica Species Fabaceae Eukaryota stem bark n.a. n.a. PMID[17489632]
NPO8526 Erythrina abyssinica Species Fabaceae Eukaryota n.a. stem n.a. PMID[18484536]
NPO8526 Erythrina abyssinica Species Fabaceae Eukaryota stem bark Mukono, Uganda 2005-JUN PMID[19008110]
NPO8526 Erythrina abyssinica Species Fabaceae Eukaryota n.a. n.a. n.a. PMID[19299148]
NPO8526 Erythrina abyssinica Species Fabaceae Eukaryota n.a. n.a. n.a. PMID[19836230]
NPO8526 Erythrina abyssinica Species Fabaceae Eukaryota n.a. n.a. n.a. PMID[20337486]
NPO8526 Erythrina abyssinica Species Fabaceae Eukaryota n.a. n.a. n.a. PMID[21116437]
NPO8526 Erythrina abyssinica Species Fabaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO8526 Erythrina abyssinica Species Fabaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO8526 Erythrina abyssinica Species Fabaceae Eukaryota n.a. n.a. n.a. Database[TCM_Taiwan]
NPO8526 Erythrina abyssinica Species Fabaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT178 Individual Protein Protein-tyrosine phosphatase 1B Homo sapiens IC50 = 14900.0 nM PMID[541823]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC474021 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
1.0 High Similarity NPC474023
0.9931 High Similarity NPC475790
0.9796 High Similarity NPC477958
0.9728 High Similarity NPC472583
0.9728 High Similarity NPC223701
0.9728 High Similarity NPC469405
0.9728 High Similarity NPC7989
0.9726 High Similarity NPC471677
0.9726 High Similarity NPC263384
0.9726 High Similarity NPC472422
0.9726 High Similarity NPC472420
0.9726 High Similarity NPC471676
0.9726 High Similarity NPC244577
0.9662 High Similarity NPC259710
0.9662 High Similarity NPC304207
0.9662 High Similarity NPC217706
0.9662 High Similarity NPC207809
0.9662 High Similarity NPC48579
0.966 High Similarity NPC161881
0.966 High Similarity NPC10807
0.966 High Similarity NPC56232
0.966 High Similarity NPC150123
0.966 High Similarity NPC244583
0.96 High Similarity NPC473990
0.9595 High Similarity NPC326592
0.9595 High Similarity NPC112701
0.9595 High Similarity NPC109594
0.9595 High Similarity NPC180301
0.9595 High Similarity NPC248793
0.9592 High Similarity NPC262038
0.9592 High Similarity NPC254412
0.9592 High Similarity NPC319910
0.9592 High Similarity NPC472636
0.9592 High Similarity NPC328740
0.9592 High Similarity NPC289774
0.9592 High Similarity NPC278476
0.9592 High Similarity NPC209846
0.9592 High Similarity NPC477897
0.9592 High Similarity NPC262039
0.9589 High Similarity NPC472628
0.9586 High Similarity NPC472627
0.9586 High Similarity NPC85773
0.9586 High Similarity NPC473133
0.9586 High Similarity NPC47388
0.9586 High Similarity NPC470670
0.9586 High Similarity NPC91902
0.9583 High Similarity NPC470890
0.9536 High Similarity NPC471976
0.9536 High Similarity NPC174953
0.953 High Similarity NPC304745
0.953 High Similarity NPC470681
0.953 High Similarity NPC111341
0.9527 High Similarity NPC35567
0.9527 High Similarity NPC243171
0.9527 High Similarity NPC473996
0.9527 High Similarity NPC216035
0.9527 High Similarity NPC138288
0.9527 High Similarity NPC217149
0.9527 High Similarity NPC171651
0.9524 High Similarity NPC105136
0.9521 High Similarity NPC10097
0.9517 High Similarity NPC474302
0.9517 High Similarity NPC472629
0.9474 High Similarity NPC3629
0.9474 High Similarity NPC472632
0.9467 High Similarity NPC20530
0.9467 High Similarity NPC78492
0.9467 High Similarity NPC208152
0.9467 High Similarity NPC215917
0.9467 High Similarity NPC10754
0.9463 High Similarity NPC311579
0.9463 High Similarity NPC268193
0.9463 High Similarity NPC293286
0.9463 High Similarity NPC20907
0.9463 High Similarity NPC236756
0.9463 High Similarity NPC244250
0.9459 High Similarity NPC474772
0.9459 High Similarity NPC474744
0.9459 High Similarity NPC472423
0.9459 High Similarity NPC472580
0.9459 High Similarity NPC471675
0.9456 High Similarity NPC5173
0.9456 High Similarity NPC89442
0.9456 High Similarity NPC307052
0.9456 High Similarity NPC473016
0.9456 High Similarity NPC139966
0.9452 High Similarity NPC473077
0.9452 High Similarity NPC296998
0.9448 High Similarity NPC87486
0.9448 High Similarity NPC224714
0.9448 High Similarity NPC124780
0.9412 High Similarity NPC474033
0.9412 High Similarity NPC474034
0.9408 High Similarity NPC475784
0.9404 High Similarity NPC471209
0.94 High Similarity NPC476169
0.94 High Similarity NPC477530
0.9396 High Similarity NPC256141
0.9396 High Similarity NPC327269
0.9396 High Similarity NPC210597
0.9396 High Similarity NPC477957
0.9396 High Similarity NPC285623
0.9396 High Similarity NPC476238
0.9396 High Similarity NPC31627
0.9392 High Similarity NPC124478
0.9392 High Similarity NPC177308
0.9392 High Similarity NPC472421
0.9392 High Similarity NPC472633
0.9384 High Similarity NPC67805
0.9384 High Similarity NPC312973
0.9384 High Similarity NPC83357
0.9384 High Similarity NPC176229
0.9384 High Similarity NPC195621
0.9384 High Similarity NPC316769
0.9384 High Similarity NPC187282
0.9384 High Similarity NPC214774
0.9384 High Similarity NPC142405
0.9384 High Similarity NPC267375
0.9384 High Similarity NPC475052
0.9384 High Similarity NPC88964
0.9384 High Similarity NPC301276
0.9384 High Similarity NPC470647
0.9384 High Similarity NPC290133
0.9384 High Similarity NPC246948
0.9384 High Similarity NPC54577
0.9384 High Similarity NPC111786
0.9384 High Similarity NPC20488
0.9384 High Similarity NPC24136
0.9379 High Similarity NPC478086
0.9379 High Similarity NPC112749
0.9379 High Similarity NPC316816
0.9379 High Similarity NPC214166
0.9379 High Similarity NPC18886
0.9375 High Similarity NPC96408
0.9375 High Similarity NPC258630
0.9375 High Similarity NPC17170
0.9375 High Similarity NPC156190
0.9375 High Similarity NPC279650
0.9375 High Similarity NPC166689
0.9346 High Similarity NPC471211
0.9346 High Similarity NPC474038
0.9346 High Similarity NPC134783
0.9346 High Similarity NPC471212
0.9346 High Similarity NPC471210
0.9338 High Similarity NPC146636
0.9333 High Similarity NPC88983
0.9333 High Similarity NPC74924
0.9333 High Similarity NPC209760
0.9333 High Similarity NPC203080
0.9333 High Similarity NPC100134
0.932 High Similarity NPC3779
0.932 High Similarity NPC44721
0.932 High Similarity NPC23728
0.932 High Similarity NPC211466
0.932 High Similarity NPC476182
0.932 High Similarity NPC40086
0.932 High Similarity NPC472918
0.932 High Similarity NPC283234
0.932 High Similarity NPC202494
0.932 High Similarity NPC122828
0.932 High Similarity NPC176869
0.932 High Similarity NPC51070
0.932 High Similarity NPC110303
0.932 High Similarity NPC222298
0.9315 High Similarity NPC131579
0.9315 High Similarity NPC131568
0.9315 High Similarity NPC209040
0.931 High Similarity NPC194432
0.931 High Similarity NPC227579
0.931 High Similarity NPC64915
0.931 High Similarity NPC166482
0.931 High Similarity NPC107572
0.931 High Similarity NPC76372
0.931 High Similarity NPC223500
0.931 High Similarity NPC78
0.931 High Similarity NPC125855
0.931 High Similarity NPC228504
0.931 High Similarity NPC32739
0.931 High Similarity NPC76338
0.931 High Similarity NPC324134
0.931 High Similarity NPC167624
0.931 High Similarity NPC161506
0.931 High Similarity NPC328164
0.931 High Similarity NPC148757
0.931 High Similarity NPC296917
0.931 High Similarity NPC324436
0.931 High Similarity NPC66515
0.931 High Similarity NPC177354
0.931 High Similarity NPC37496
0.931 High Similarity NPC182852
0.931 High Similarity NPC40833
0.931 High Similarity NPC166934
0.931 High Similarity NPC306829
0.931 High Similarity NPC220998
0.931 High Similarity NPC265040
0.931 High Similarity NPC10937
0.931 High Similarity NPC1089
0.9286 High Similarity NPC44947
0.9286 High Similarity NPC259834
0.9281 High Similarity NPC118256

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC474021 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.9392 High Similarity NPD4380 Phase 2
0.9205 High Similarity NPD2393 Clinical (unspecified phase)
0.9054 High Similarity NPD4378 Clinical (unspecified phase)
0.9026 High Similarity NPD7075 Discontinued
0.9026 High Similarity NPD4381 Clinical (unspecified phase)
0.9013 High Similarity NPD1934 Approved
0.8994 High Similarity NPD7804 Clinical (unspecified phase)
0.8966 High Similarity NPD1550 Clinical (unspecified phase)
0.8966 High Similarity NPD1552 Clinical (unspecified phase)
0.8954 High Similarity NPD7096 Clinical (unspecified phase)
0.8924 High Similarity NPD6167 Clinical (unspecified phase)
0.8924 High Similarity NPD6166 Phase 2
0.8924 High Similarity NPD6168 Clinical (unspecified phase)
0.8904 High Similarity NPD1549 Phase 2
0.8896 High Similarity NPD8443 Clinical (unspecified phase)
0.88 High Similarity NPD7410 Clinical (unspecified phase)
0.8766 High Similarity NPD6801 Discontinued
0.8734 High Similarity NPD6959 Discontinued
0.8704 High Similarity NPD7074 Phase 3
0.8701 High Similarity NPD7411 Suspended
0.8642 High Similarity NPD7054 Approved
0.8639 High Similarity NPD2796 Approved
0.859 High Similarity NPD2801 Approved
0.8589 High Similarity NPD7472 Approved
0.8571 High Similarity NPD1510 Phase 2
0.8553 High Similarity NPD5494 Approved
0.8537 High Similarity NPD6797 Phase 2
0.8487 Intermediate Similarity NPD6799 Approved
0.8487 Intermediate Similarity NPD1511 Approved
0.8485 Intermediate Similarity NPD7251 Discontinued
0.8481 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.8471 Intermediate Similarity NPD7819 Suspended
0.8434 Intermediate Similarity NPD7808 Phase 3
0.8425 Intermediate Similarity NPD1240 Approved
0.8377 Intermediate Similarity NPD1512 Approved
0.8373 Intermediate Similarity NPD6559 Discontinued
0.8365 Intermediate Similarity NPD3882 Suspended
0.8354 Intermediate Similarity NPD3818 Discontinued
0.8344 Intermediate Similarity NPD7852 Clinical (unspecified phase)
0.8323 Intermediate Similarity NPD5403 Approved
0.8311 Intermediate Similarity NPD1607 Approved
0.8302 Intermediate Similarity NPD3817 Phase 2
0.828 Intermediate Similarity NPD6599 Discontinued
0.825 Intermediate Similarity NPD7768 Phase 2
0.8224 Intermediate Similarity NPD2800 Approved
0.8214 Intermediate Similarity NPD4338 Clinical (unspecified phase)
0.8204 Intermediate Similarity NPD7993 Clinical (unspecified phase)
0.8194 Intermediate Similarity NPD5401 Approved
0.8193 Intermediate Similarity NPD5844 Phase 1
0.8187 Intermediate Similarity NPD5402 Approved
0.8105 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.8086 Intermediate Similarity NPD3749 Approved
0.8052 Intermediate Similarity NPD3750 Approved
0.8052 Intermediate Similarity NPD4628 Phase 3
0.8 Intermediate Similarity NPD6232 Discontinued
0.7964 Intermediate Similarity NPD7473 Discontinued
0.7962 Intermediate Similarity NPD2533 Approved
0.7962 Intermediate Similarity NPD2532 Approved
0.7962 Intermediate Similarity NPD2534 Approved
0.7947 Intermediate Similarity NPD6651 Approved
0.7922 Intermediate Similarity NPD970 Clinical (unspecified phase)
0.7919 Intermediate Similarity NPD4907 Clinical (unspecified phase)
0.7919 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.7908 Intermediate Similarity NPD2935 Discontinued
0.7908 Intermediate Similarity NPD1551 Phase 2
0.7901 Intermediate Similarity NPD1465 Phase 2
0.7895 Intermediate Similarity NPD4419 Clinical (unspecified phase)
0.7871 Intermediate Similarity NPD1243 Approved
0.7862 Intermediate Similarity NPD920 Approved
0.7853 Intermediate Similarity NPD4360 Phase 2
0.7853 Intermediate Similarity NPD4363 Phase 3
0.7841 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.7815 Intermediate Similarity NPD1613 Approved
0.7815 Intermediate Similarity NPD1612 Clinical (unspecified phase)
0.7792 Intermediate Similarity NPD6100 Approved
0.7792 Intermediate Similarity NPD6099 Approved
0.7785 Intermediate Similarity NPD4908 Phase 1
0.7778 Intermediate Similarity NPD5953 Discontinued
0.7772 Intermediate Similarity NPD7584 Approved
0.7765 Intermediate Similarity NPD7286 Phase 2
0.7765 Intermediate Similarity NPD8090 Clinical (unspecified phase)
0.7763 Intermediate Similarity NPD5124 Phase 1
0.7763 Intermediate Similarity NPD5123 Clinical (unspecified phase)
0.7746 Intermediate Similarity NPD8312 Approved
0.7746 Intermediate Similarity NPD8313 Approved
0.7736 Intermediate Similarity NPD642 Clinical (unspecified phase)
0.7727 Intermediate Similarity NPD2799 Discontinued
0.7727 Intermediate Similarity NPD3748 Approved
0.7727 Intermediate Similarity NPD7033 Discontinued
0.7722 Intermediate Similarity NPD643 Clinical (unspecified phase)
0.7707 Intermediate Similarity NPD1878 Clinical (unspecified phase)
0.7706 Intermediate Similarity NPD3751 Discontinued
0.7692 Intermediate Similarity NPD2424 Discontinued
0.7683 Intermediate Similarity NPD8455 Phase 2
0.7682 Intermediate Similarity NPD2313 Discontinued
0.7679 Intermediate Similarity NPD3787 Discontinued
0.7673 Intermediate Similarity NPD7390 Discontinued
0.7671 Intermediate Similarity NPD1547 Clinical (unspecified phase)
0.7628 Intermediate Similarity NPD2344 Approved
0.7619 Intermediate Similarity NPD1247 Approved
0.7613 Intermediate Similarity NPD1509 Clinical (unspecified phase)
0.7605 Intermediate Similarity NPD919 Approved
0.76 Intermediate Similarity NPD1530 Clinical (unspecified phase)
0.7595 Intermediate Similarity NPD6398 Clinical (unspecified phase)
0.7582 Intermediate Similarity NPD943 Approved
0.7561 Intermediate Similarity NPD7615 Clinical (unspecified phase)
0.7551 Intermediate Similarity NPD1610 Phase 2
0.755 Intermediate Similarity NPD1529 Clinical (unspecified phase)
0.7546 Intermediate Similarity NPD3226 Approved
0.7541 Intermediate Similarity NPD6781 Approved
0.7541 Intermediate Similarity NPD6780 Approved
0.7541 Intermediate Similarity NPD6782 Approved
0.7541 Intermediate Similarity NPD6776 Approved
0.7541 Intermediate Similarity NPD6778 Approved
0.7541 Intermediate Similarity NPD6777 Approved
0.7541 Intermediate Similarity NPD6779 Approved
0.7516 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.7516 Intermediate Similarity NPD2346 Discontinued
0.75 Intermediate Similarity NPD3027 Phase 3
0.75 Intermediate Similarity NPD8151 Discontinued
0.7471 Intermediate Similarity NPD5710 Approved
0.7471 Intermediate Similarity NPD5711 Approved
0.7471 Intermediate Similarity NPD3823 Discontinued
0.7467 Intermediate Similarity NPD1203 Approved
0.7451 Intermediate Similarity NPD6798 Discontinued
0.7439 Intermediate Similarity NPD7458 Discontinued
0.7439 Intermediate Similarity NPD5808 Clinical (unspecified phase)
0.7438 Intermediate Similarity NPD2309 Approved
0.7434 Intermediate Similarity NPD6832 Phase 2
0.7427 Intermediate Similarity NPD3926 Phase 2
0.7421 Intermediate Similarity NPD7783 Phase 2
0.7421 Intermediate Similarity NPD1652 Phase 2
0.7421 Intermediate Similarity NPD7782 Clinical (unspecified phase)
0.7419 Intermediate Similarity NPD7698 Approved
0.7419 Intermediate Similarity NPD7696 Phase 3
0.7419 Intermediate Similarity NPD7697 Approved
0.7419 Intermediate Similarity NPD7435 Discontinued
0.7419 Intermediate Similarity NPD230 Phase 1
0.7418 Intermediate Similarity NPD4361 Phase 2
0.7418 Intermediate Similarity NPD4362 Clinical (unspecified phase)
0.7416 Intermediate Similarity NPD8434 Phase 2
0.7416 Intermediate Similarity NPD8150 Discontinued
0.7399 Intermediate Similarity NPD7228 Approved
0.7397 Intermediate Similarity NPD1548 Phase 1
0.7386 Intermediate Similarity NPD4625 Phase 3
0.7354 Intermediate Similarity NPD7585 Approved
0.7354 Intermediate Similarity NPD7701 Phase 2
0.7351 Intermediate Similarity NPD7501 Clinical (unspecified phase)
0.7338 Intermediate Similarity NPD3268 Approved
0.7338 Intermediate Similarity NPD6410 Clinical (unspecified phase)
0.7333 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.7317 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.7312 Intermediate Similarity NPD2654 Approved
0.731 Intermediate Similarity NPD7199 Phase 2
0.7308 Intermediate Similarity NPD6355 Discontinued
0.7308 Intermediate Similarity NPD1933 Approved
0.7305 Intermediate Similarity NPD6844 Discontinued
0.7305 Intermediate Similarity NPD37 Approved
0.7303 Intermediate Similarity NPD2798 Approved
0.7302 Intermediate Similarity NPD7583 Approved
0.7301 Intermediate Similarity NPD4662 Approved
0.7301 Intermediate Similarity NPD4661 Approved
0.7294 Intermediate Similarity NPD6234 Discontinued
0.729 Intermediate Similarity NPD6233 Phase 2
0.7287 Intermediate Similarity NPD7870 Phase 2
0.7287 Intermediate Similarity NPD7871 Phase 2
0.7283 Intermediate Similarity NPD2403 Approved
0.7278 Intermediate Similarity NPD4308 Phase 3
0.7278 Intermediate Similarity NPD4967 Phase 2
0.7278 Intermediate Similarity NPD4966 Approved
0.7278 Intermediate Similarity NPD4965 Approved
0.7273 Intermediate Similarity NPD6823 Phase 2
0.7268 Intermediate Similarity NPD6535 Approved
0.7268 Intermediate Similarity NPD6534 Approved
0.7267 Intermediate Similarity NPD9717 Approved
0.7263 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.7243 Intermediate Similarity NPD7699 Phase 2
0.7243 Intermediate Similarity NPD7700 Phase 2
0.7237 Intermediate Similarity NPD2797 Approved
0.7222 Intermediate Similarity NPD6190 Approved
0.7219 Intermediate Similarity NPD4749 Approved
0.7216 Intermediate Similarity NPD1729 Discontinued
0.7215 Intermediate Similarity NPD4537 Clinical (unspecified phase)
0.7215 Intermediate Similarity NPD4536 Approved
0.7215 Intermediate Similarity NPD4538 Approved
0.7205 Intermediate Similarity NPD5698 Clinical (unspecified phase)
0.72 Intermediate Similarity NPD422 Phase 1
0.7197 Intermediate Similarity NPD447 Suspended
0.7197 Intermediate Similarity NPD1899 Clinical (unspecified phase)
0.7188 Intermediate Similarity NPD7875 Clinical (unspecified phase)
0.7188 Intermediate Similarity NPD7874 Approved
0.7184 Intermediate Similarity NPD7784 Clinical (unspecified phase)
0.7171 Intermediate Similarity NPD3225 Approved
0.7169 Intermediate Similarity NPD1653 Approved
0.7168 Intermediate Similarity NPD7229 Phase 3
0.716 Intermediate Similarity NPD5760 Phase 2
0.716 Intermediate Similarity NPD5761 Phase 2
0.7152 Intermediate Similarity NPD5049 Phase 3
0.715 Intermediate Similarity NPD7801 Approved
0.7143 Intermediate Similarity NPD2861 Phase 2

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data